616 related articles for article (PubMed ID: 34718591)
1. Estimated SARS-CoV-2 infection rate and fatality risk in Gauteng Province, South Africa: a population-based seroepidemiological survey.
Mutevedzi PC; Kawonga M; Kwatra G; Moultrie A; Baillie V; Mabena N; Mathibe MN; Rafuma MM; Maposa I; Abbott G; Hugo J; Ikalafeng B; Adelekan T; Lukhele M; Madhi SA
Int J Epidemiol; 2022 May; 51(2):404-417. PubMed ID: 34718591
[TBL] [Abstract][Full Text] [Related]
2. Population Immunity and Covid-19 Severity with Omicron Variant in South Africa.
Madhi SA; Kwatra G; Myers JE; Jassat W; Dhar N; Mukendi CK; Nana AJ; Blumberg L; Welch R; Ngorima-Mabhena N; Mutevedzi PC
N Engl J Med; 2022 Apr; 386(14):1314-1326. PubMed ID: 35196424
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020.
Murhekar MV; Bhatnagar T; Selvaraju S; Rade K; Saravanakumar V; Vivian Thangaraj JW; Kumar MS; Shah N; Sabarinathan R; Turuk A; Anand PK; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chakraborty D; Rangaraju C; Chopra V; Das D; Deb AK; Devi KR; Dwivedi GR; Salim Khan SM; Haq I; Kumar MS; Laxmaiah A; Madhuka ; Mahapatra A; Mitra A; Nirmala AR; Pagdhune A; Qurieshi MA; Ramarao T; Sahay S; Sharma YK; Shrinivasa MB; Shukla VK; Singh PK; Viramgami A; Wilson VC; Yadav R; Girish Kumar CP; Luke HE; Ranganathan UD; Babu S; Sekar K; Yadav PD; Sapkal GN; Das A; Das P; Dutta S; Hemalatha R; Kumar A; Narain K; Narasimhaiah S; Panda S; Pati S; Patil S; Sarkar K; Singh S; Kant R; Tripathy S; Toteja GS; Babu GR; Kant S; Muliyil JP; Pandey RM; Sarkar S; Singh SK; Zodpey S; Gangakhedkar RR; S Reddy DC; Bhargava B
Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):48-60. PubMed ID: 32952144
[TBL] [Abstract][Full Text] [Related]
4. Infection fatality risk for SARS-CoV-2 in community dwelling population of Spain: nationwide seroepidemiological study.
Pastor-Barriuso R; Pérez-Gómez B; Hernán MA; Pérez-Olmeda M; Yotti R; Oteo-Iglesias J; Sanmartín JL; León-Gómez I; Fernández-García A; Fernández-Navarro P; Cruz I; Martín M; Delgado-Sanz C; Fernández de Larrea N; León Paniagua J; Muñoz-Montalvo JF; Blanco F; Larrauri A; Pollán M;
BMJ; 2020 Nov; 371():m4509. PubMed ID: 33246972
[TBL] [Abstract][Full Text] [Related]
5. Sustained Low Incidence of Severe and Fatal COVID-19 Following Widespread Infection Induced Immunity after the Omicron (BA.1) Dominant in Gauteng, South Africa: An Observational Study.
Madhi SA; Kwatra G; Myers JE; Jassat W; Dhar N; Mukendi CK; Blumberg L; Welch R; Izu A; Mutevedzi PC
Viruses; 2023 Feb; 15(3):. PubMed ID: 36992306
[TBL] [Abstract][Full Text] [Related]
6. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis.
COVID-19 Cumulative Infection Collaborators
Lancet; 2022 Jun; 399(10344):2351-2380. PubMed ID: 35405084
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey.
Murhekar MV; Bhatnagar T; Selvaraju S; Saravanakumar V; Thangaraj JWV; Shah N; Kumar MS; Rade K; Sabarinathan R; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chopra V; Das D; Deb AK; Devi KR; Dwivedi GR; Khan SMS; Kumar CPG; Kumar MS; Laxmaiah A; Madhukar M; Mahapatra A; Mohanty SS; Rangaraju C; Turuk A; Baradwaj DK; Chahal AS; Debnath F; Haq I; Kalliath A; Kanungo S; Kshatri JS; Lakshmi GGJN; Mitra A; Nirmala AR; Prasad GV; Qurieshi MA; Sahay S; Sangwan RK; Sekar K; Shukla VK; Singh PK; Singh P; Singh R; Varma DS; Viramgami A; Panda S; Reddy DCS; Bhargava B;
Lancet Glob Health; 2021 Mar; 9(3):e257-e266. PubMed ID: 33515512
[TBL] [Abstract][Full Text] [Related]
8. Trends in seroprevalence of SARS-CoV-2 and infection fatality rate in the Norwegian population through the first year of the COVID-19 pandemic.
Tunheim G; Rø GØI; Tran T; Kran AB; Andersen JT; Vaage EB; Kolderup A; Vaage JT; Lund-Johansen F; Hungnes O
Influenza Other Respir Viruses; 2022 Mar; 16(2):204-212. PubMed ID: 34751488
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Seroprevalence in a Rural and Urban Household Cohort during First and Second Waves of Infections, South Africa, July 2020-March 2021.
Kleynhans J; Tempia S; Wolter N; von Gottberg A; Bhiman JN; Buys A; Moyes J; McMorrow ML; Kahn K; Gómez-Olivé FX; Tollman S; Martinson NA; Wafawanaka F; Lebina L; du Toit J; Jassat W; Neti M; Brauer M; Cohen C;
Emerg Infect Dis; 2021 Dec; 27(12):3020-3029. PubMed ID: 34477548
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study.
Laxminarayan R; B CM; G VT; Arjun Kumar KV; Wahl B; Lewnard JA
Lancet Infect Dis; 2021 Dec; 21(12):1665-1676. PubMed ID: 34399090
[TBL] [Abstract][Full Text] [Related]
11. The evolution and interpretation of seroprevalence of SARS-CoV-2 antibodies among South African blood donors from the Beta to Omicron variant-driven waves.
Vermeulen M; Mhlanga L; Sykes W; Cable R; Coleman C; Pietersen N; Swanevelder R; Glatt TN; Bingham J; van den Berg K; Grebe E; Welte A
Vox Sang; 2024 Mar; 119(3):242-251. PubMed ID: 38156504
[TBL] [Abstract][Full Text] [Related]
12. Estimation of SARS-CoV-2 Infection Fatality Rate by Age and Comorbidity Status Using Antibody Screening of Blood Donors During the COVID-19 Epidemic in Denmark.
Kaspersen KA; Hindhede L; Boldsen JK; Mikkelsen S; Vestergaard LS; Berthelsen AN; Moustsen-Helms IR; Holm DK; Nilsson AC; Sækmose SG; Sørensen E; Harritshøj LH; Aagaard B; Hjalgrim H; Lillevang ST; Jørgensen CS; Krause TG; Ullum H; Pedersen OBV; Ostrowski SR; Erikstrup C
J Infect Dis; 2022 Jan; 225(2):219-228. PubMed ID: 34788834
[TBL] [Abstract][Full Text] [Related]
13. First wave of SARS-CoV-2 in Santiago Chile: Seroprevalence, asymptomatic infection and infection fatality rate.
Vial PA; González C; Apablaza M; Vial C; Lavín ME; Araos R; Rubilar P; Icaza G; Florea A; Pérez C; Concha P; Bastías D; Errázuriz MP; Pérez R; Guzmán F; Olea A; Guzmán E; Correa J; Munita JM; Aguilera X
Epidemics; 2022 Sep; 40():100606. PubMed ID: 35872438
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020-January 2021.
Murhekar MV; Bhatnagar T; Thangaraj JWV; Saravanakumar V; Kumar MS; Selvaraju S; Rade K; Kumar CPG; Sabarinathan R; Turuk A; Asthana S; Balachandar R; Bangar SD; Bansal AK; Chopra V; Das D; Deb AK; Devi KR; Dhikav V; Dwivedi GR; Khan SMS; Kumar MS; Laxmaiah A; Madhukar M; Mahapatra A; Rangaraju C; Turuk J; Yadav R; Andhalkar R; Arunraj K; Bharadwaj DK; Bharti P; Bhattacharya D; Bhat J; Chahal AS; Chakraborty D; Chaudhury A; Deval H; Dhatrak S; Dayal R; Elantamilan D; Giridharan P; Haq I; Hudda RK; Jagjeevan B; Kalliath A; Kanungo S; Krishnan NN; Kshatri JS; Kumar A; Kumar N; Kumar VGV; Lakshmi GGJN; Mehta G; Mishra NK; Mitra A; Nagbhushanam K; Nimmathota A; Nirmala AR; Pandey AK; Prasad GV; Qurieshi MA; Reddy SD; Robinson A; Sahay S; Saxena R; Sekar K; Shukla VK; Singh HB; Singh PK; Singh P; Singh R; Srinivasan N; Varma DS; Viramgami A; Wilson VC; Yadav S; Yadav S; Zaman K; Chakrabarti A; Das A; Dhaliwal RS; Dutta S; Kant R; Khan AM; Narain K; Narasimhaiah S; Padmapriyadarshini C; Pandey K; Pati S; Patil S; Rajkumar H; Ramarao T; Sharma YK; Singh S; Panda S; Reddy DCS; Bhargava B;
Int J Infect Dis; 2021 Jul; 108():145-155. PubMed ID: 34022338
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 infection- induced seroprevalence among children and associated risk factors during the pre- and omicron-dominant wave, from January 2021 through December 2022, Thailand: A longitudinal study.
Suntronwong N; Vichaiwattana P; Klinfueng S; Puenpa J; Kanokudom S; Assawakosri S; Chansaenroj J; Srimuan D; Thatsanatorn T; Songtaisarana S; Sudhinaraset N; Wanlapakorn N; Poovorawan Y
PLoS One; 2023; 18(4):e0279147. PubMed ID: 37104299
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of SARS-CoV-2-specific IgG antibodies in Kashmir, India, 7 months after the first reported local COVID-19 case: results of a population-based seroprevalence survey from October to November 2020.
Khan SMS; Qurieshi MA; Haq I; Majid S; Ahmad J; Ayub T; Bhat AA; Fazili AB; Ganai AM; Jan Y; Kaul RU; Khan ZA; Masoodi MA; Mushtaq B; Nazir F; Nazir M; Raja MW; Rasool M; Asma A; Ayoub S; Aziz M; Bhat AA; Chowdri IN; Ismail S; Kawoosa MF; Khan MA; Khan MS; Kousar R; Lone AA; Nabi S; Obaid M; Qazi TB; Sabah I; Sumji IA
BMJ Open; 2021 Sep; 11(9):e053791. PubMed ID: 34556519
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of SARS-CoV-2 Infection in Portugal in May-July 2020: Results of the First National Serological Survey (ISNCOVID-19).
Kislaya I; Gonçalves P; Barreto M; Sousa R; Garcia AC; Matos R; Guiomar R; Rodrigues AP;
Acta Med Port; 2021 Feb; 34(2):87-94. PubMed ID: 33641702
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 IgG in Juba, South Sudan, 2020
Wiens KE; Mawien PN; Rumunu J; Slater D; Jones FK; Moheed S; Caflisch A; Bior BK; Jacob IA; Lako RL; Guyo AG; Olu OO; Maleghemi S; Baguma A; Hassen JJ; Baya SK; Deng L; Lessler J; Demby MN; Sanchez V; Mills R; Fraser C; Charles RC; Harris JB; Azman AS; Wamala JF
Emerg Infect Dis; 2021 Jun; 27(6):1598-1606. PubMed ID: 34013872
[TBL] [Abstract][Full Text] [Related]
19. High seroprevalence of SARS-CoV-2 but low infection fatality ratio eight months after introduction in Nairobi, Kenya.
Ngere I; Dawa J; Hunsperger E; Otieno N; Masika M; Amoth P; Makayotto L; Nasimiyu C; Gunn BM; Nyawanda B; Oluga O; Ngunu C; Mirieri H; Gachohi J; Marwanga D; Munywoki PK; Odhiambo D; Alando MD; Breiman RF; Anzala O; Njenga MK; Bulterys M; Herman-Roloff A; Osoro E
Int J Infect Dis; 2021 Nov; 112():25-34. PubMed ID: 34481966
[TBL] [Abstract][Full Text] [Related]
20. Estimation of SARS-CoV-2 Infection Fatality Rate by Real-time Antibody Screening of Blood Donors.
Erikstrup C; Hother CE; Pedersen OBV; Mølbak K; Skov RL; Holm DK; Sækmose SG; Nilsson AC; Brooks PT; Boldsen JK; Mikkelsen C; Gybel-Brask M; Sørensen E; Dinh KM; Mikkelsen S; Møller BK; Haunstrup T; Harritshøj L; Jensen BA; Hjalgrim H; Lillevang ST; Ullum H
Clin Infect Dis; 2021 Jan; 72(2):249-253. PubMed ID: 33501969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
